The presence of an operational classification of drug interactions (ORCA) class 3 or 4 drug-drug interactions (DDIs) did not increase the risk for colchicine-related gastrointestinal adverse events or ...

The media reports that colchicine, a very old drug, has now been discovered to reduce the risk of recurrent heart disease and has a new FDA indication. Of course, the “discovery” has taken 10 years, ...

Dear Dr. Roach: I’m a 78-year-old man with a stent and a blockage in one of the arteries to my heart. I am on a low-fat diet and take ramipril for cholesterol. My levels are very good (total ...

Please provide your email address to receive an email when new articles are posted on . More than 25% of patients with gout who use colchicine prophylaxis were on potentially interacting medications.

Depending on one’s perspective, the anti-inflammatory colchicine is either an unsung and underprescribed drug for patients with cardiovascular disease, or it’s an agent with limited clinical benefit ...

AMSTERDAM, the Netherlands—The use of colchicine just before major thoracic surgery and for 10 days afterwards does not lower the risk of clinically significant atrial fibrillation (AF) or myocardial ...

The drug colchicine may reduce cardiovascular outcomes among patients with gout, based on a range of retrospective data that suggest improved outcomes and mechanistic connections between gout and ...

Please provide your email address to receive an email when new articles are posted on . WASHINGTON — The use of colchicine for gout flare prevention imparts a “modest” decrease in the risk for knee or ...